Home>Topics>Funds>iShares Nasdaq Biotechnology

iShares Nasdaq Biotechnology

  1. All
  2. Commentary
  3. Fund Reports
  4. ETF Reports
  5. Headlines
  1. XBI SPDR S&P Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Tue, 2 Sep 2014

    market-cap-weighted option is iShares Nasdaq Biotechnology IBB , which holds 121 Nasdaq-listed ..... market cap of $16.3 billion. IBB charges an expense ratio of 0 ..... holding cost of just 0.27%. IBB has a low price tag, historically

  2. FBT First Trust NYSE Arca Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Tue, 2 Sep 2014

    market-cap-weighted option is iShares Nasdaq Biotechnology IBB , which holds 121 Nasdaq-listed ..... market cap of $16.3 billion. IBB charges an expense ratio of 0 ..... holding cost of just 0.23%. IBB has a low price tag, historically

  3. IBB iShares Nasdaq Biotechnology ETF Analysis, Report, Research, 5 Star Rating – Morningstar

    ETF Reports

    Tue, 2 Sep 2014

    Still, we think that IBB 's price tag is quite reasonable ..... New York Stock Exchange.) IBB 's index is one of eight ..... industry can consider adding iShares Nasdaq Biotechnology to their portfolios as a tactical ..... more sway. As a result, IBB has been less volatile over

  4. Today's Market: Red Hot Biotech And Big Pharma Names To Watch

    Headlines

    Fri, 29 Aug 2014

    By Matthew Smith : A busy week is about to come to an end, but not before we have learned a lot about the strength of this market and just how resilient it is. Some will point to the weak volume over the past few sessions, but that is to be expected this time of year. Factoring in that volatility

  5. Where Are The Opportunities In U.S. Health Care?

    Headlines

    Thu, 28 Aug 2014

    By Morningstar : By Robert Goldsborough Since the start of 2014, the U.S. health-care sector has continued its recent track record of outpacing the broader U.S. equity market, topping the S&P 500 Index by more than 400 basis points. Over the past three years, health-care stocks have in aggregate ...

  6. Roche deal stokes biotech sector

    Headlines

    Mon, 25 Aug 2014

    Roche's ( OTCQX:RHHBY +0.6% ) $8.3B acquisition of InterMune ( ITMN +35.7% ) fuels an inflow of money into the biotech sector today. The iShares NASDAQ Biotech Index ETF ( IBB +2.2% ) is up on average volume. ETFs: BIB , BIS Post your comment!

  7. Quite A Comeback For This Momentum ETF

    Headlines

    Thu, 21 Aug 2014

    beloved exchange traded funds such as the Global X Social Media Index ETF (NASDAQ: SOCL ) and the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB ) to ominous flirtations with bear markets . Imagine how bad things were during the March/April

  8. Like I said, we're almost free of Ebola

    Headlines

    Wed, 20 Aug 2014

    Chukwu said that Nigeria had only two known cases of Ebola and the county would be free of the disease within a week. The outbreak has sickened 2,240 people to date with 1,229 fatalities. ETFs: IBB , BIB , IRY , IXJ , BIS Post your comment!

  9. New Issue- IBB prices 100 mln euro 2022 FRN

    Headlines

    Thu, 14 Aug 2014

    Notes Launched under issuer's Debt Issuance Programme

  10. New Issue- IBB prices 50 mln euro 2019 FRN

    Headlines

    Thu, 14 Aug 2014

    Notes Launched under issuer's Debt Issuance Programme

« Prev1234Next »
Content Partners